We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRQR icon
1301
ProQR Therapeutics
PRQR
$244M
$2.1M 0.01%
+317,705
New +$1.62M
VCRA
1302
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$2.1M 0.01%
54,603
+34,403
+170% +$1.48M
SILK
1303
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$2.09M 0.01%
41,288
-428,134
-91% -$23.8M
AKICW
1304
CALL
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$2.08M 0.01%
+216,661
New +$239K
CWK icon
1305
Cushman & Wakefield Ltd
CWK
$3.2B
$2.07M 0.01%
126,927
+99,185
+358% +$1.55M
APEN
1306
DELISTED
Apollo Endosurgery, Inc.
APEN
$2.07M 0.01%
+375,299
New +$1.86M
JFU
1307
9F Inc
JFU
$23.5M
$2.06M 0.01%
55,635
+37,326
+204% +$1.28M
MC icon
1308
Moelis & Co
MC
$5.09B
$2.06M 0.01%
37,504
+21,336
+132% +$1.14M
TGI
1309
DELISTED
Triumph Group
TGI
$2.06M 0.01%
111,863
+64,538
+136% +$964K
SPNS
1310
DELISTED
Sapiens International
SPNS
$2.06M 0.01%
64,641
-50,623
-44% -$1.64M
XYL icon
1311
Xylem
XYL
$29.6B
$2.05M 0.01%
+19,469
New +$1.97M
GB.WS
1312
CALL
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$2.04M 0.01%
167,896
VIR icon
1313
Vir Biotechnology
VIR
$1.48B
$2.03M 0.01%
+39,560
New +$2.13M
LUV icon
1314
CALL
Southwest Airlines
LUV
$22.5B
$2.03M 0.01%
+33,200
New +$1.77M
COLIU
1315
DELISTED
Colicity Inc. Units
COLIU
$2.02M 0.01%
+200,000
New +$2.04M
FRO icon
1316
Frontline
FRO
$8.62B
$2.02M 0.01%
278,164
-86,549
-24% -$596K
SCPE.WS
1317
CALL
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$2.02M 0.01%
199,999
CCRC
1318
DELISTED
China Customer Relations Centers, Inc
CCRC
$2.02M 0.01%
+330,903
New +$1.58M
SPGS.U
1319
DELISTED
Simon Property Group Acquisition Holdings, Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
SPGS.U
$2.01M 0.01%
+200,000
New +$2.06M
SNII.U
1320
DELISTED
Supernova Partners Acquisition Company II, Ltd. Units, each consisting of one Class A ordinary share
SNII.U
$2.01M 0.01%
+200,000
New +$2.03M
PTCT icon
1321
PTC Therapeutics
PTCT
$6.09B
$2M 0.01%
+42,257
New +$2.51M
SMRT icon
1322
SmartRent
SMRT
$193M
$2M 0.01%
+200,000
New +$2.11M
IGMS
1323
DELISTED
IGM Biosciences
IGMS
$2M 0.01%
+26,046
New +$2.37M
NXRT
1324
NexPoint Residential Trust
NXRT
$695M
$2M 0.01%
43,284
+16,045
+59% +$687K
BNY
1325
Bank of New York Mellon
BNY
$106B
$1.99M 0.01%
42,125
-1,313,662
-97% -$57.8M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.